SHANGHAI, Oct. 13, 2015 /PRNewswire/ -- WuXi PharmaTech
(Cayman) Inc. (NYSE: WX), a leading open-access R&D
capability and technology platform company serving the
pharmaceutical, biotechnology, and medical device industries, today
announced that it has launched a mobile version of OncoWuXi, the
first App in the world to allow researchers to access oncology
models and data on the go. The OncoWuXi App helps WuXi's
clients anywhere and at any time to identify relevant tumor models
for use in anti-tumor efficacy testing to facilitate oncology drug
discovery and translational oncology, as well as to keep up-to-date
on WuXi's capabilities and services in this area.
The OncoWuXi App provides users with a portable oncology
database for selection and inquiry of the more than 1,000 cancer
patient-derived xenograft (PDX), human cancer cell-derived
xenograft (CDX), and syngeneic mouse tumor models available at
WuXi. Its backend database covers every aspect of those
models, including growth dynamics, histopathology, clinical
information, genomic profiles, and Standard of Care (SoC)
validation data. Users may also submit service requests
regarding particular models from the App directly to WuXi
Oncology.
The App can be used on either Apple or Android devices and is
available for download at both the Apple App store and Google
Play. Its corresponding web-based browser,
http://onco.wuxiapptec.com/, was launched in China in June and is also accessible
globally.
"WuXi has long been committed to bringing our customers the most
advanced products and services for discovering and developing
innovative drugs," said Dr. Ge Li,
Chairman and CEO of WuXi PharmaTech. "Beginning with WuXi
V-Lab, the first mobile app available to the global research
community in need of small-molecule compound synthesis, which we
launched earlier this year, and now with OncoWuXi, we are striving
to enable our customers to access our platform capabilities and
technologies more quickly and easily."
For an Android device, OncoWuXi App can be downloaded at
http://onco.wuxiapptec.com/oncowuxi.apk.
About WuXi PharmaTech
WuXi PharmaTech is a leading open-access R&D capability and
technology platform company serving the pharmaceutical,
biotechnology, and medical device industries, with operations in
China and the United States.
As a research-driven and customer-focused company, WuXi PharmaTech
provides a broad and integrated portfolio of services throughout
the drug and medical device R&D process. WuXi is also
building a platform to provide clinical diagnostic services
directly to physicians and their patients globally. WuXi
PharmaTech's services are designed to assist its global partners in
shortening the cycle and lowering the cost of drug and medical
device R&D. WuXi PharmaTech's operating subsidiaries are
known as WuXi AppTec. For more information, please visit:
http://www.wuxiapptec.com.
For more information, please contact:
Ronald Aldridge (for
investors)
LaVoieHealthScience
+1-617-374-8800 x109
+1 617-792-2459
ir@wuxiapptec.com
Aaron Shi (for the media)
Director, Corporate Communications
WuXi PharmaTech
+86-21-5046-4362
pr@wuxiapptec.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/wuxi-pharmatech-launches-mobile-oncowuxi-the-worlds-first-app-for-accessing-oncology-models-300158608.html
SOURCE WuXi PharmaTech (Cayman) Inc.